Sign in
BIOR Stock Price, Chart, Stats & News
Biora Therapeutics, Inc.
Save
Biora Therapeutics, Inc. (BIOR) does not currently pay a dividend.
994,994
Market cap
0.61x
Current P/E
–
Forward P/E
BIOR chart
About
Health care
Sector
Biotechnology
Industry
Biora Therapeutics, Inc. is a biotechnology company focused on developing cutting-edge oral biotherapeutic solutions. The company's core efforts involve two main therapeutic programs: Targeted Therapeutics: This program utilizes an advanced ingestible smart capsule designed to deliver medications precisely within the gastrointestinal (GI) tract. The aim is to significantly improve therapies for inflammatory bowel diseases.
Similar securities
Based on sector and market capitalization
Report issue